JP2020511114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511114A5 JP2020511114A5 JP2019530815A JP2019530815A JP2020511114A5 JP 2020511114 A5 JP2020511114 A5 JP 2020511114A5 JP 2019530815 A JP2019530815 A JP 2019530815A JP 2019530815 A JP2019530815 A JP 2019530815A JP 2020511114 A5 JP2020511114 A5 JP 2020511114A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- acid sequence
- amino acid
- seq
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1620968.6 | 2016-12-09 | ||
| GBGB1620968.6A GB201620968D0 (en) | 2016-12-09 | 2016-12-09 | Adenovirus polynucleotides and polypeptides |
| PCT/IB2017/057738 WO2018104911A1 (en) | 2016-12-09 | 2017-12-07 | Adenovirus polynucleotides and polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020511114A JP2020511114A (ja) | 2020-04-16 |
| JP2020511114A5 true JP2020511114A5 (cg-RX-API-DMAC7.html) | 2021-01-21 |
Family
ID=58222021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530815A Pending JP2020511114A (ja) | 2016-12-09 | 2017-12-07 | アデノウイルスポリヌクレオチド及びポリペプチド |
Country Status (15)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201507393TA (en) | 2013-03-14 | 2015-10-29 | Salk Inst For Biological Studi | Oncolytic adenovirus compositions |
| ES2899913T3 (es) | 2014-09-24 | 2022-03-15 | Salk Inst For Biological Studi | Virus tumorales oncolíticos y métodos de uso |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP3390645B1 (en) | 2016-02-23 | 2022-09-14 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| AU2017375633C1 (en) | 2016-12-12 | 2023-04-27 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| KR102945203B1 (ko) | 2017-05-08 | 2026-03-31 | 시애틀 프로젝트 코포레이션 | 알파바이러스 신생항원 벡터 |
| CN111108203A (zh) * | 2017-07-17 | 2020-05-05 | 葛兰素史密丝克莱恩生物有限公司 | 狂犬病病毒抗原构建体 |
| SG11202003058UA (en) * | 2017-10-16 | 2020-04-29 | Glaxosmithkline Biologicals Sa | Replication competent adenoviral vectors |
| BR112020019942A2 (pt) | 2018-04-09 | 2021-01-26 | Salk Institute For Biological Studies | composições de adenovírus oncolítico com propriedades de replicação aprimoradas |
| MX2020013553A (es) | 2018-06-12 | 2021-02-26 | Glaxosmithkline Biologicals Sa | Polinucleotidos y polipeptidos de adenovirus. |
| BR112021000965A2 (pt) | 2018-08-07 | 2021-04-27 | Glaxosmithkline Biologicals S.A. | processos e vacinas |
| KR20210090650A (ko) | 2018-11-07 | 2021-07-20 | 그릿스톤 바이오, 인코포레이티드 | 알파바이러스 신생항원 벡터 및 인터페론 억제제 |
| EP3897846A1 (en) | 2018-12-21 | 2021-10-27 | GlaxoSmithKline Biologicals SA | Methods of inducing an immune response |
| SG11202113187WA (en) | 2019-05-30 | 2021-12-30 | Gritstone Bio Inc | Modified adenoviruses |
| WO2021156489A1 (en) * | 2020-02-05 | 2021-08-12 | Imophoron Limited | Engineered polypeptides derived from variable domain of adenovirus penton base |
| EP4133090A1 (en) * | 2020-04-07 | 2023-02-15 | Lung Biotechnology PBC | Adenoviral expression vector and methods and cell lines for production |
| IL300026A (en) | 2020-08-06 | 2023-03-01 | Gritstone Bio Inc | Multiepitope vaccine cassettes |
| GB202016139D0 (en) * | 2020-10-12 | 2020-11-25 | Ospedale San Raffaele | Polynucleotide |
| JP2025523458A (ja) * | 2022-06-22 | 2025-07-23 | アスクバイオ インコーポレイテッド | アデノウイルスに基づく核酸およびその方法 |
| CN121816424A (zh) * | 2023-08-11 | 2026-04-07 | 拜奥卡德联合股份公司 | 用于生产基于腺相关病毒(AAV)的载体(变体)的腺病毒E2a基因的修饰的序列 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US5240846A (en) | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| JP3723231B2 (ja) | 1991-12-23 | 2005-12-07 | ディミナコ アクチェンゲゼルシャフト | アジュバント |
| DE69313134T2 (de) | 1992-06-25 | 1998-02-26 | Smithkline Beecham Biolog | Adjuvantien enthaltende impfstoffzusammensetzung |
| KR100310510B1 (ko) | 1993-03-23 | 2002-07-04 | 장 스테판느 | 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물 |
| PT729473E (pt) | 1993-11-17 | 2001-02-28 | Deutsche Om Arzneimittel Gmbh | Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| GB9620795D0 (en) | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
| CA2264482A1 (en) | 1996-09-06 | 1998-03-12 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6083716A (en) | 1996-09-06 | 2000-07-04 | The Trustees Of The University Of Pennsylvania | Chimpanzee adenovirus vectors |
| WO1998016247A1 (en) | 1996-10-11 | 1998-04-23 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| US6764840B2 (en) | 1997-05-08 | 2004-07-20 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| AU734180B2 (en) | 1997-08-29 | 2001-06-07 | Antigenics Llc | Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
| EP1279401B1 (en) | 1997-09-05 | 2008-01-09 | GlaxoSmithKline Biologicals S.A. | Oil in water emulsions containing saponins |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| WO2000011140A1 (en) | 1998-08-20 | 2000-03-02 | The Wistar Institute Of Anatomy And Biology | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
| ES2284287T3 (es) | 1998-10-16 | 2007-11-01 | Glaxosmithkline Biologicals S.A. | Sistemas adyuvantes y vacunas. |
| US7291498B2 (en) | 2003-06-20 | 2007-11-06 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| JP4814800B2 (ja) * | 2004-01-23 | 2011-11-16 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | チンパンジーアデノウイルスワクチン担体 |
| CA2610919C (en) | 2005-06-17 | 2013-09-10 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Hepatitis c virus nucleic acid vaccine |
| SI1957528T1 (sl) | 2005-11-30 | 2013-02-28 | University Of Copenhagen | Nukleotidno cepivo |
| EP2181121A4 (en) | 2007-03-21 | 2012-07-11 | Id Biomedical Corp Quebec | CHIMÄRE ANTIGENE |
| CN102131920B (zh) * | 2007-11-28 | 2013-11-06 | 宾夕法尼亚大学托管会 | 猿猴亚家族C腺病毒SAdV-40、-31和-34及其应用 |
| SI2865387T1 (sl) | 2008-11-21 | 2019-10-30 | Kobenhavns Univ University Of Copenhagen | Primiranje imunskega odziva |
| HUE039908T2 (hu) | 2009-02-02 | 2019-02-28 | Glaxosmithkline Biologicals Sa | Majom adenovírusból származó nukleinsav- és aminosav-szekvenciák, azt tartalmazó vektorok és alkalmazásuk |
| WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| JP6091435B2 (ja) | 2011-02-22 | 2017-03-08 | カリフォルニア インスティチュート オブ テクノロジー | アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達 |
| WO2016198621A1 (en) | 2015-06-12 | 2016-12-15 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
-
2016
- 2016-12-09 GB GBGB1620968.6A patent/GB201620968D0/en not_active Ceased
-
2017
- 2017-12-07 MX MX2019006725A patent/MX2019006725A/es unknown
- 2017-12-07 CN CN201780074539.3A patent/CN110300597A/zh active Pending
- 2017-12-07 AR ARP170103442A patent/AR110502A1/es unknown
- 2017-12-07 JP JP2019530815A patent/JP2020511114A/ja active Pending
- 2017-12-07 EA EA201991116A patent/EA201991116A1/ru unknown
- 2017-12-07 BE BE2017/5910A patent/BE1025029B1/fr not_active IP Right Cessation
- 2017-12-07 EP EP17838152.1A patent/EP3551224A1/en active Pending
- 2017-12-07 BR BR112019010906A patent/BR112019010906A2/pt not_active IP Right Cessation
- 2017-12-07 US US16/466,683 patent/US11414679B2/en active Active
- 2017-12-07 KR KR1020197018883A patent/KR20190092471A/ko not_active Ceased
- 2017-12-07 AU AU2017371944A patent/AU2017371944B2/en not_active Ceased
- 2017-12-07 CA CA3045973A patent/CA3045973A1/en active Pending
- 2017-12-07 WO PCT/IB2017/057738 patent/WO2018104911A1/en not_active Ceased
-
2019
- 2019-05-28 IL IL266942A patent/IL266942A/en unknown
-
2022
- 2022-05-11 US US17/742,221 patent/US11795478B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018524977A5 (cg-RX-API-DMAC7.html) | ||
| JP7274222B2 (ja) | 非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用 | |
| JP2020511940A5 (cg-RX-API-DMAC7.html) | ||
| AU737780B2 (en) | Methods and reagents for vaccination which generate a CD8 T cell immune response | |
| JP6873054B2 (ja) | アデノウイルスポリヌクレオチド及びポリペプチド | |
| JP7630466B2 (ja) | 抗原がインバリアント鎖(cd74)の小断片と連結された融合ペプチド | |
| JP7274223B2 (ja) | マイクロサテライト不安定性(msi)癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン | |
| JP2018523980A5 (cg-RX-API-DMAC7.html) | ||
| US20210269486A1 (en) | Chimpanzee adenovirus constructs with lyssavirus antigens | |
| JP2012516679A5 (cg-RX-API-DMAC7.html) | ||
| JP2026082958A (ja) | ゴリラ・アデノウイルスの核酸配列およびアミノ酸配列、それを含むベクター、およびそれらの使用 | |
| JP2021526831A (ja) | アデノウイルスポリヌクレオチド及びポリペプチド | |
| CN118308379A (zh) | 爱泼斯坦-巴尔病毒抗原构建体 | |
| HK40031047A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| HK40031047B (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| AU775973B2 (en) | Methods and reagents for vaccination which generate a CD8 T cell immune response | |
| AU2004203141B2 (en) | Methods and reagents for vaccination which generate CD8 T cell immune response | |
| NZ759892B2 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |